Reed Business Information, Online
May 26, 2004
Please join DRUG DISCOVERY& DEVELOPMENT magazine and a panel of industry experts as we discuss early-stage ADME screening, the tools and technology available for pre-clinical pharmacokinetic testing of compounds, and their predictive value in drug development. It’s an ideal opportunity to: - Learn about new ADME screening tools from case studies by pharmaceutical researchers who make daily “go”/“no go” decisions about pursuing therapeutic programs. - Interact with the panelists during the live webcast to ask technical and scientific questions about how best to incorporate available technologies in early stage ADME screening.
|
|
Invited Speakers:
|
|
- Tanuja Koppal, PhD, Senior Editor, DRUG DISCOVERY & DEVELOPMENT - JoAnn Scatina, PhD; Assistant Vice President, Drug Safety and Metabolism, Wyeth Pharmaceuticals- Navita L. Mallalieu, PhD, Senior Principal Scientist, Discovery Pharmacology, Hoffmann-La Roche - Bernard Faller, PhD, Head, Profiling Group, Basel Discovery Technologies, Novartis
|
|